Le prix des médicaments anticancéreux est-il justifié ?
Crossref DOI link: https://doi.org/10.1007/s10269-017-2736-7
Published Online: 2018-01-11
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guillot, B.
License valid from 2017-11-01